| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 308.11 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 204.562 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 198.759 | 83 |
| GSM780719 | Untreated after 4 days (C1_2) | 293.478 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 201.371 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 214.962 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 198.552 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 274.319 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 273.925 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 206.511 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 291.079 | 87 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 311.162 | 88 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 312.745 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 230.405 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 296.136 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 321.771 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 233.613 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 279.44 | 87 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 278.847 | 87 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 287.432 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 237.825 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 258.433 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 248.865 | 86 |